APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neuroblastoma Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Neuroblastoma Treatment Industry Growth and Trends Forecast to 2032

19 December 2025103 pages

Choose your research edition.

Industry ResearchNeuroblastoma Treatment Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Neuroblastoma Treatment Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Neuroblastoma Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neuroblastoma Treatment Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Neuroblastoma Treatment Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

According to APO Research, the global Neuroblastoma Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Neuroblastoma Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Neuroblastoma Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neuroblastoma Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Neuroblastoma Treatment market include Adaptimmune, CureSearch, Juno Therapeutics, Kite Pharma, NANT, Seattle Children’s, Texas Children’s, Fosun Pharmaceutical and Jiangsu Hengrui Medicine Co.,Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Neuroblastoma Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Neuroblastoma Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Neuroblastoma Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Neuroblastoma Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Neuroblastoma Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Neuroblastoma Treatment Market by Company

Adaptimmune

CureSearch

Juno Therapeutics

Kite Pharma

NANT

Seattle Children’s

Texas Children’s

Fosun Pharmaceutical

Jiangsu Hengrui Medicine Co.,Ltd.

Novartis

Sino Biopharmaceutical

Neuroblastoma Treatment Segment by Type

Vaccine Therapy

Oncolytic Virus Therapy

Chimeric Antigen Receptor T-Cell Immunotherapy

Combination Chemotherapy

Monoclonal Antibody Therapy

Neuroblastoma Treatment Segment by Application

Hospitals

Clinics

Others

Neuroblastoma Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neuroblastoma Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neuroblastoma Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neuroblastoma Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Neuroblastoma Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Neuroblastoma Treatment Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Neuroblastoma Treatment Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Neuroblastoma Treatment Market Share by Region (2021-2026) Table 4. Global Neuroblastoma Treatment Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Neuroblastoma Treatment Market Share by Region (2027-2032) Table 6. Global Neuroblastoma Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Neuroblastoma Treatment Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Neuroblastoma Treatment Market Size Share by Type (2021-2026) Table 9. Global Neuroblastoma Treatment Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Neuroblastoma Treatment Market Size Share Forecasted by Type (2027-2032) Table 11. North America Neuroblastoma Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Neuroblastoma Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Neuroblastoma Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Neuroblastoma Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Neuroblastoma Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Neuroblastoma Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Neuroblastoma Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Neuroblastoma Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Neuroblastoma Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Neuroblastoma Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Neuroblastoma Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Neuroblastoma Treatment Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Neuroblastoma Treatment Market Size Share by Application (2021-2026) Table 24. Global Neuroblastoma Treatment Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Neuroblastoma Treatment Market Size Share Forecasted by Application (2027-2032) Table 26. North America Neuroblastoma Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Neuroblastoma Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Neuroblastoma Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Neuroblastoma Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Neuroblastoma Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Neuroblastoma Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Neuroblastoma Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Neuroblastoma Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Neuroblastoma Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Neuroblastoma Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Neuroblastoma Treatment Industry Trends Table 37. Neuroblastoma Treatment Industry Drivers Table 38. Neuroblastoma Treatment Industry Opportunities and Challenges Table 39. Neuroblastoma Treatment Industry Restraints Table 40. Global Neuroblastoma Treatment Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Neuroblastoma Treatment Revenue Market Share by Company (2021-2026) Table 42. Global Neuroblastoma Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Neuroblastoma Treatment Key Company Headquarters & Area Served Table 44. Global Neuroblastoma Treatment Company, Product Type & Application Table 45. Global Neuroblastoma Treatment Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Neuroblastoma Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Adaptimmune Company Information Table 49. Adaptimmune Business Overview Table 50. Adaptimmune Neuroblastoma Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Adaptimmune Neuroblastoma Treatment Product Portfolio Table 52. Adaptimmune Recent Development Table 53. CureSearch Company Information Table 54. CureSearch Business Overview Table 55. CureSearch Neuroblastoma Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. CureSearch Neuroblastoma Treatment Product Portfolio Table 57. CureSearch Recent Development Table 58. Juno Therapeutics Company Information Table 59. Juno Therapeutics Business Overview Table 60. Juno Therapeutics Neuroblastoma Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Juno Therapeutics Neuroblastoma Treatment Product Portfolio Table 62. Juno Therapeutics Recent Development Table 63. Kite Pharma Company Information Table 64. Kite Pharma Business Overview Table 65. Kite Pharma Neuroblastoma Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Kite Pharma Neuroblastoma Treatment Product Portfolio Table 67. Kite Pharma Recent Development Table 68. NANT Company Information Table 69. NANT Business Overview Table 70. NANT Neuroblastoma Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. NANT Neuroblastoma Treatment Product Portfolio Table 72. NANT Recent Development Table 73. Seattle Children’s Company Information Table 74. Seattle Children’s Business Overview Table 75. Seattle Children’s Neuroblastoma Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Seattle Children’s Neuroblastoma Treatment Product Portfolio Table 77. Seattle Children’s Recent Development Table 78. Texas Children’s Company Information Table 79. Texas Children’s Business Overview Table 80. Texas Children’s Neuroblastoma Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Texas Children’s Neuroblastoma Treatment Product Portfolio Table 82. Texas Children’s Recent Development Table 83. Fosun Pharmaceutical Company Information Table 84. Fosun Pharmaceutical Business Overview Table 85. Fosun Pharmaceutical Neuroblastoma Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Fosun Pharmaceutical Neuroblastoma Treatment Product Portfolio Table 87. Fosun Pharmaceutical Recent Development Table 88. Jiangsu Hengrui Medicine Co.,Ltd. Company Information Table 89. Jiangsu Hengrui Medicine Co.,Ltd. Business Overview Table 90. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Product Portfolio Table 92. Jiangsu Hengrui Medicine Co.,Ltd. Recent Development Table 93. Novartis Company Information Table 94. Novartis Business Overview Table 95. Novartis Neuroblastoma Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Novartis Neuroblastoma Treatment Product Portfolio Table 97. Novartis Recent Development Table 98. Sino Biopharmaceutical Company Information Table 99. Sino Biopharmaceutical Business Overview Table 100. Sino Biopharmaceutical Neuroblastoma Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Sino Biopharmaceutical Neuroblastoma Treatment Product Portfolio Table 102. Sino Biopharmaceutical Recent Development Table 103. North America Neuroblastoma Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Neuroblastoma Treatment Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Neuroblastoma Treatment Market Share by Country (2021-2026) Table 106. North America Neuroblastoma Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Neuroblastoma Treatment Market Share Forecast by Country (2027-2032) Table 108. Europe Neuroblastoma Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Europe Neuroblastoma Treatment Market Size by Country (2021-2026) & (US$ Million) Table 110. Europe Neuroblastoma Treatment Market Share by Country (2021-2026) Table 111. Europe Neuroblastoma Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Europe Neuroblastoma Treatment Market Share Forecast by Country (2027-2032) Table 113. Asia-Pacific Neuroblastoma Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Asia-Pacific Neuroblastoma Treatment Market Size by Country (2021-2026) & (US$ Million) Table 115. Asia-Pacific Neuroblastoma Treatment Market Share by Country (2021-2026) Table 116. Asia-Pacific Neuroblastoma Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Asia-Pacific Neuroblastoma Treatment Market Share Forecast by Country (2027-2032) Table 118. Latin America Neuroblastoma Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Latin America Neuroblastoma Treatment Market Size by Country (2021-2026) & (US$ Million) Table 120. Latin America Neuroblastoma Treatment Market Share by Country (2021-2026) Table 121. Latin America Neuroblastoma Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Latin America Neuroblastoma Treatment Market Share Forecast by Country (2027-2032) Table 123. Middle East & Africa Neuroblastoma Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Middle East & Africa Neuroblastoma Treatment Market Size by Country (2021-2026) & (US$ Million) Table 125. Middle East & Africa Neuroblastoma Treatment Market Share by Country (2021-2026) Table 126. Middle East & Africa Neuroblastoma Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Middle East & Africa Neuroblastoma Treatment Market Share Forecast by Country (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Neuroblastoma Treatment Product Image Figure 3. Global Neuroblastoma Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Neuroblastoma Treatment Market Size (2021-2032) & (US$ Million) Figure 5. Global Neuroblastoma Treatment Market Share by Region: 2025 VS 2032 Figure 6. Global Neuroblastoma Treatment Market Share by Region (2021-2032) Figure 7. North America Neuroblastoma Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Neuroblastoma Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Neuroblastoma Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Neuroblastoma Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Neuroblastoma Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Vaccine Therapy Image Figure 13. Global Vaccine Therapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Oncolytic Virus Therapy Image Figure 15. Global Oncolytic Virus Therapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Chimeric Antigen Receptor T-Cell Immunotherapy Image Figure 17. Global Chimeric Antigen Receptor T-Cell Immunotherapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Combination Chemotherapy Image Figure 19. Global Combination Chemotherapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Monoclonal Antibody Therapy Image Figure 21. Global Monoclonal Antibody Therapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Neuroblastoma Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Neuroblastoma Treatment Market Share by Type 2025 VS 2032 Figure 24. North America Neuroblastoma Treatment Market Size Share by Type (2021-2032) Figure 25. Europe Neuroblastoma Treatment Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Neuroblastoma Treatment Market Size Share by Type (2021-2032) Figure 27. Latin America Neuroblastoma Treatment Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Neuroblastoma Treatment Market Size Share by Type (2021-2032) Figure 29. Hospitals Image Figure 30. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Clinics Image Figure 32. Global Clinics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Others Image Figure 34. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Neuroblastoma Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Neuroblastoma Treatment Market Share by Application 2025 VS 2032 Figure 37. North America Neuroblastoma Treatment Market Size Share by Application (2021-2032) Figure 38. Europe Neuroblastoma Treatment Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Neuroblastoma Treatment Market Size Share by Application (2021-2032) Figure 40. Latin America Neuroblastoma Treatment Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Neuroblastoma Treatment Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Neuroblastoma Treatment Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Neuroblastoma Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Neuroblastoma Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Neuroblastoma Treatment Market Share by Country (2021-2032) Figure 47. Europe Neuroblastoma Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Neuroblastoma Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Neuroblastoma Treatment Market Share by Country (2021-2032) Figure 50. Asia-Pacific Neuroblastoma Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Neuroblastoma Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Neuroblastoma Treatment Market Share by Country (2021-2032) Figure 53. Latin America Neuroblastoma Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Neuroblastoma Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Neuroblastoma Treatment Market Share by Country (2021-2032) Figure 56. Middle East & Africa Neuroblastoma Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Neuroblastoma Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Neuroblastoma Treatment Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Vaccine Therapy
  • Oncolytic Virus Therapy
  • Chimeric Antigen Receptor T-Cell Immunotherapy
  • Combination Chemotherapy
  • Monoclonal Antibody Therapy
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Adaptimmune
  • CureSearch
  • Juno Therapeutics
  • Kite Pharma
  • NANT
  • Seattle Children’s
  • Texas Children’s
  • Fosun Pharmaceutical
  • Jiangsu Hengrui Medicine Co.,Ltd.
  • Novartis
  • Sino Biopharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Neuroblastoma Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Neuroblastoma Treatment Market Size by Region (2021-2032)
  5. 1.4.1 Global Neuroblastoma Treatment Market Size by Region (2021-2026)
  6. 1.4.2 Global Neuroblastoma Treatment Market Size by Region (2027-2032)
  7. 1.5 Key Regions Neuroblastoma Treatment Market Size (2021-2032)
  8. 1.5.1 North America Neuroblastoma Treatment Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Neuroblastoma Treatment Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Neuroblastoma Treatment Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Neuroblastoma Treatment Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Neuroblastoma Treatment Market Size Growth Rate (2021-2032)
2 Neuroblastoma Treatment Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Vaccine Therapy
  3. 2.1.2 Oncolytic Virus Therapy
  4. 2.1.3 Chimeric Antigen Receptor T-Cell Immunotherapy
  5. 2.1.4 Combination Chemotherapy
  6. 2.1.5 Monoclonal Antibody Therapy
  7. 2.2 Global Neuroblastoma Treatment Market Size by Type
  8. 2.2.1 Global Neuroblastoma Treatment Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Neuroblastoma Treatment Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Neuroblastoma Treatment Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Neuroblastoma Treatment Market Size by Regions
  12. 2.3.1 North America Neuroblastoma Treatment Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Neuroblastoma Treatment Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Neuroblastoma Treatment Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Neuroblastoma Treatment Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Neuroblastoma Treatment Market Size Breakdown by Type (2021-2026)
3 Neuroblastoma Treatment Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospitals
  3. 3.1.2 Clinics
  4. 3.1.3 Others
  5. 3.2 Global Neuroblastoma Treatment Market Size by Application
  6. 3.2.1 Global Neuroblastoma Treatment Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Neuroblastoma Treatment Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Neuroblastoma Treatment Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Neuroblastoma Treatment Market Size by Regions
  10. 3.3.1 North America Neuroblastoma Treatment Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Neuroblastoma Treatment Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Neuroblastoma Treatment Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Neuroblastoma Treatment Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Neuroblastoma Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Neuroblastoma Treatment Industry Trends
  2. 4.2 Neuroblastoma Treatment Industry Drivers
  3. 4.3 Neuroblastoma Treatment Industry Opportunities and Challenges
  4. 4.4 Neuroblastoma Treatment Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Neuroblastoma Treatment Revenue (2021-2026)
  2. 5.2 Global Neuroblastoma Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Neuroblastoma Treatment Key Company Headquarters & Area Served
  4. 5.4 Global Neuroblastoma Treatment Company, Product Type & Application
  5. 5.5 Global Neuroblastoma Treatment Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Neuroblastoma Treatment Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Neuroblastoma Treatment Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Neuroblastoma Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Adaptimmune
  2. 6.1.1 Adaptimmune Company Information
  3. 6.1.2 Adaptimmune Business Overview
  4. 6.1.3 Adaptimmune Neuroblastoma Treatment Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Adaptimmune Neuroblastoma Treatment Product Portfolio
  6. 6.1.5 Adaptimmune Recent Developments
  7. 6.2 CureSearch
  8. 6.2.1 CureSearch Company Information
  9. 6.2.2 CureSearch Business Overview
  10. 6.2.3 CureSearch Neuroblastoma Treatment Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 CureSearch Neuroblastoma Treatment Product Portfolio
  12. 6.2.5 CureSearch Recent Developments
  13. 6.3 Juno Therapeutics
  14. 6.3.1 Juno Therapeutics Company Information
  15. 6.3.2 Juno Therapeutics Business Overview
  16. 6.3.3 Juno Therapeutics Neuroblastoma Treatment Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Juno Therapeutics Neuroblastoma Treatment Product Portfolio
  18. 6.3.5 Juno Therapeutics Recent Developments
  19. 6.4 Kite Pharma
  20. 6.4.1 Kite Pharma Company Information
  21. 6.4.2 Kite Pharma Business Overview
  22. 6.4.3 Kite Pharma Neuroblastoma Treatment Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Kite Pharma Neuroblastoma Treatment Product Portfolio
  24. 6.4.5 Kite Pharma Recent Developments
  25. 6.5 NANT
  26. 6.5.1 NANT Company Information
  27. 6.5.2 NANT Business Overview
  28. 6.5.3 NANT Neuroblastoma Treatment Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 NANT Neuroblastoma Treatment Product Portfolio
  30. 6.5.5 NANT Recent Developments
  31. 6.6 Seattle Children’s
  32. 6.6.1 Seattle Children’s Company Information
  33. 6.6.2 Seattle Children’s Business Overview
  34. 6.6.3 Seattle Children’s Neuroblastoma Treatment Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Seattle Children’s Neuroblastoma Treatment Product Portfolio
  36. 6.6.5 Seattle Children’s Recent Developments
  37. 6.7 Texas Children’s
  38. 6.7.1 Texas Children’s Company Information
  39. 6.7.2 Texas Children’s Business Overview
  40. 6.7.3 Texas Children’s Neuroblastoma Treatment Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Texas Children’s Neuroblastoma Treatment Product Portfolio
  42. 6.7.5 Texas Children’s Recent Developments
  43. 6.8 Fosun Pharmaceutical
  44. 6.8.1 Fosun Pharmaceutical Company Information
  45. 6.8.2 Fosun Pharmaceutical Business Overview
  46. 6.8.3 Fosun Pharmaceutical Neuroblastoma Treatment Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Fosun Pharmaceutical Neuroblastoma Treatment Product Portfolio
  48. 6.8.5 Fosun Pharmaceutical Recent Developments
  49. 6.9 Jiangsu Hengrui Medicine Co.,Ltd.
  50. 6.9.1 Jiangsu Hengrui Medicine Co.,Ltd. Company Information
  51. 6.9.2 Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
  52. 6.9.3 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Product Portfolio
  54. 6.9.5 Jiangsu Hengrui Medicine Co.,Ltd. Recent Developments
  55. 6.10 Novartis
  56. 6.10.1 Novartis Company Information
  57. 6.10.2 Novartis Business Overview
  58. 6.10.3 Novartis Neuroblastoma Treatment Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Novartis Neuroblastoma Treatment Product Portfolio
  60. 6.10.5 Novartis Recent Developments
  61. 6.11 Sino Biopharmaceutical
  62. 6.11.1 Sino Biopharmaceutical Company Information
  63. 6.11.2 Sino Biopharmaceutical Business Overview
  64. 6.11.3 Sino Biopharmaceutical Neuroblastoma Treatment Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Sino Biopharmaceutical Neuroblastoma Treatment Product Portfolio
  66. 6.11.5 Sino Biopharmaceutical Recent Developments
7 North America
  1. 7.1 North America Neuroblastoma Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Neuroblastoma Treatment Market Size by Country (2021-2026)
  3. 7.3 North America Neuroblastoma Treatment Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Neuroblastoma Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Neuroblastoma Treatment Market Size by Country (2021-2026)
  3. 8.3 Europe Neuroblastoma Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Neuroblastoma Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Neuroblastoma Treatment Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Neuroblastoma Treatment Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Neuroblastoma Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Neuroblastoma Treatment Market Size by Country (2021-2026)
  3. 10.3 South America Neuroblastoma Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Neuroblastoma Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Neuroblastoma Treatment Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Neuroblastoma Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst